Exogenous human surfactant for treatment of severe respiratory distress syndrome: A randomized prospective clinical trial

The Journal of Pediatrics

Volumn 106, Issue 6, 1985, Pages 963-969

  Hallman, Mikko ^a,b   Merritt, T Allen ^a,b   Jarvenpaa, Anna Liisa ^a,b   Boynton, Bruce ^a,b   Mannino, Frank ^a,b   Gluck, Louis ^a,b   Moore, Thomas ^a,b   Edwards, David ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT;

CONTROLLED STUDY; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY SYSTEM; THERAPY;

AMNIOTIC FLUID; BIRTH WEIGHT; CLINICAL TRIALS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; MALE; PROSPECTIVE STUDIES; RANDOM ALLOCATION; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SURFACE-ACTIVE AGENTS; TIME FACTORS;

EID: 0021819963     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(85)80253-5     Document Type: Article

References (20)

1. Surface properties in relation to atelectasis and hyaline membrane disease
2. Isolation of human surfactant from amniotic fluid and a pilot study of its efficacy in respiratory distress syndrome
3. Immune complex formation in respiratory distress syndrome
4. Artificial surfactant therapy in hyaline membrane diseases
5. Dry artificial lung surfactant and its effect on very premature babies
6. Hyaline membrane disease treated with bovine surfactant
7. Controlled trial of artificial surfactant to prevent respiratory distress syndrome
8. Absence of phosphatidylglycerol (PG) in respiratory distress syndrome in the newborn
9. The management of respiratory distress syndrome
10. Incidence and evolution of subependymal and intraventricular hemorrhage A study of infants with birth weights less than 1500 gm
11. Bronchopulmonary dysplasia today
12. The arterial/alveolar oxygen tension ratio: An index of gas exchange applicable to varying oxygen concentrations
13. Inereased shunt through the patent ductus arteriosus after surfactant replacement therapy
14. Recurrence of symptomatic patent ductus arteriosus in extremely premature infants treated with indomethacin
15. Surfactant function in respiratory distress syndrome
16. Duration and characteristics of treatment of premature lambs with natural surfacant
17. Surfactaht and pulmonary blood flow distributions following treatment of premature lambs with natural surfactant